NEW YORK, March 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.
Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.
The Pipeline Developer report covers Insulin Lispro
Insulin Lispro indications: Treatment of diabetes mellitus, optionally in combination with a longer-acting insulin for type 1 diabetes or in a combination therapy with a sulfonylurea agent for type 2 diabetes
Insulin Lispro innovator: Eli Lilly (Humalog, Humalog Kwikpen, Humalog Mix 25, Humalog Mix25 Pen, Humalog Mix 50, Humalog Pen)
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.
Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.